Chronic obstructive pulmonary disease and COVID-19

Basit Öğe Kaydı
dc.contributor.authorTuran, Onur
dc.contributor.authorMirici, Arzu
dc.date.accessioned2025-01-27T20:22:57Z
dc.date.available2025-01-27T20:22:57Z
dc.date.issued2020
dc.departmentÇanakkale Onsekiz Mart Üniversitesi
dc.description.abstractThe coronavirus disease 2019 (COVID-19) pandemic tends to have a more severe clinical picture in the elderly and in patients with chronic diseases, one of which is chronic obstructive pulmonary disease (COPD). Around 2%-3% of patients infected with coronavirus have had the diagnosis of COPD; the critical care, intubation requirement, and mortality rate have been higher among this group of patients with the development of hypoxemia. Exacerbation and COVID-19 pneumonia are two differential diagnoses in patients with COPD; the fever among the symptoms, lymphopenia among the laboratory findings, and typical radiological findings in thoracic tomography of patients may be helpful in the diagnosis of COVID-19. The stabilization of the disease is important in the follow-up of patients with COPD during this pandemic; the continuation of maintenance treatment of patients has been accepted as the main strategy. Droplet and contact transmissions should be decreased, and basic hygiene and nutritional rules should be followed in the COPD patient group in which the risk of infection development is high. There are various opinions on the administration of treatment through nebulizers during the pandemic; the use of inhaler devices is the safer and recommended method. Since noninvasive mechanical ventilators may increase the risk of contamination, they are not included among the routine treatment recommendations for patients with COPD.
dc.identifier.doi10.4103/ejop.ejop_36_20
dc.identifier.endpage60
dc.identifier.issn2148-3620
dc.identifier.issn2148-5402
dc.identifier.issue4
dc.identifier.startpage56
dc.identifier.trdizinid388894
dc.identifier.urihttps://doi.org/10.4103/ejop.ejop_36_20
dc.identifier.urihttps://search.trdizin.gov.tr/tr/yayin/detay/388894
dc.identifier.urihttps://hdl.handle.net/20.500.12428/22078
dc.identifier.volume22
dc.identifier.wosWOS:000578603800012
dc.identifier.wosqualityN/A
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakTR-Dizin
dc.language.isoen
dc.publisherKare Publ
dc.relation.ispartofEurasian Journal of Pulmonology
dc.relation.publicationcategoryinfo:eu-repo/semantics/openAccess
dc.rightsinfo:eu-repo/semantics/openAccess
dc.snmzKA_WoS_20250125
dc.subjectChronic obstructive pulmonary disease
dc.subjectcoronavirus disease 2019
dc.subjecttreatment strategy
dc.titleChronic obstructive pulmonary disease and COVID-19
dc.typeReview Article

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
TR-Dizin İndeksli Yayınlar Koleksiyonu